×

Daxor Return on Tangible Equity 2010-2011 | DXR

Current and historical return on tangible equity values for Daxor (DXR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Daxor Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $-0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.037B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.257B 0.00
Quest Diagnostics (DGX) United States $16.849B 17.08
DaVita (DVA) United States $12.285B 15.89
Encompass Health (EHC) United States $9.254B 21.82
Chemed (CHE) United States $7.946B 24.42
Elanco Animal Health (ELAN) United States $5.957B 14.18
RadNet (RDNT) United States $5.193B 115.00
Option Care Health (OPCH) United States $3.863B 18.31
Amedisys (AMED) United States $2.977B 21.19
LifeStance Health (LFST) United States $2.889B 0.00
Addus HomeCare (ADUS) United States $2.253B 26.44
Astrana Health (ASTH) United States $1.811B 24.77
U.S Physical Therapy (USPH) United States $1.327B 34.87
Pennant (PNTG) United States $0.909B 36.75
Aveanna Healthcare Holdings (AVAH) United States $0.871B 0.00
Atai Life Sciences (ATAI) Germany $0.268B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Ontrak (OTRK) United States $0.008B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00